Urology Today.net

Site updated at Tuesday, 28 October 2014

Common Urological Problems

Jevtana

J&J drug offers hope in advanced prostate cancer

Men with advanced prostate cancer lived nearly four months longer on a new pill from Johnson & Johnson, according to keenly awaited study data that researchers said would change clinical practice.

Abiraterone, which could reach the market next year, provides a new option for men with an aggressive type of prostate cancer.

Its… J&J drug offers hope in advanced prostate cancer   



american journal of epidemiology1 - ngal1 - lifestyle changes1 - non-skin cancer1 - renal cancer2 - polycystic disease1 - symptomatic kidney stones1 - urea1 - aus1 - bladder frequency1 - nephron development1 - generalized edema1 - vitamin supplements1 - external sphincter dyssynergia1 - urinary arsenic1 - prostate cancer outcomes1 - myocardial infarction1 - vur1 - hemorrhagic inflammation1 - american society of nephrology20 - calcium channel1 - abdominopelvic cavity1 - seminal vesicle stones1 - early-stage prostate cancer2 - renal failure4 - cmaj2 - cause of incontinence6 - anxiety1 - ureters drain1 - cholesterol2 -